company background image
IIN

IntriConNasdaqGM:IIN Stock Report

Market Cap

US$145.8m

7D

-6.0%

1Y

-12.5%

Updated

07 Dec, 2021

Data

Company Financials +
IIN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

IIN Stock Overview

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for IntriCon
Historical stock prices
Current Share PriceUS$15.95
52 Week HighUS$28.16
52 Week LowUS$14.89
Beta1.32
1 Month Change-14.57%
3 Month Change-25.36%
1 Year Change-12.46%
3 Year Change-48.33%
5 Year Change141.67%
Change since IPO187.82%

Recent News & Updates

Nov 09
IntriCon (NASDAQ:IIN) Might Be Having Difficulty Using Its Capital Effectively

IntriCon (NASDAQ:IIN) Might Be Having Difficulty Using Its Capital Effectively

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Sep 29
IntriCon Corporation's (NASDAQ:IIN) Intrinsic Value Is Potentially 91% Above Its Share Price

IntriCon Corporation's (NASDAQ:IIN) Intrinsic Value Is Potentially 91% Above Its Share Price

In this article we are going to estimate the intrinsic value of IntriCon Corporation ( NASDAQ:IIN ) by taking the...

Aug 17
The Strong Earnings Posted By IntriCon (NASDAQ:IIN) Are A Good Indication Of The Strength Of The Business

The Strong Earnings Posted By IntriCon (NASDAQ:IIN) Are A Good Indication Of The Strength Of The Business

Even though IntriCon Corporation's ( NASDAQ:IIN ) recent earnings release was robust, the market didn't seem to notice...

Shareholder Returns

IINUS Medical EquipmentUS Market
7D-6.0%0.05%-2.6%
1Y-12.5%12.2%17.8%

Return vs Industry: IIN underperformed the US Medical Equipment industry which returned 8.9% over the past year.

Return vs Market: IIN underperformed the US Market which returned 16.5% over the past year.

Price Volatility

Is IIN's price volatile compared to industry and market?
IIN volatility
IIN Average Weekly Movement7.1%
Medical Equipment Industry Average Movement7.6%
Market Average Movement6.2%
10% most volatile stocks in US Market14.8%
10% least volatile stocks in US Market2.4%

Stable Share Price: IIN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: IIN's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1930762J. Longvalhttps://www.intricon.com

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology, and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers.

IntriCon Fundamentals Summary

How do IntriCon's earnings and revenue compare to its market cap?
IIN fundamental statistics
Market CapUS$145.83m
Earnings (TTM)US$964.00k
Revenue (TTM)US$123.33m

151.3x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IIN income statement (TTM)
RevenueUS$123.33m
Cost of RevenueUS$92.27m
Gross ProfitUS$31.07m
ExpensesUS$30.10m
EarningsUS$964.00k

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin25.19%
Net Profit Margin0.78%
Debt/Equity Ratio0%

How did IIN perform over the long term?

See historical performance and comparison

Valuation

Is IntriCon undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: IIN ($15.95) is trading below our estimate of fair value ($41.26)

Significantly Below Fair Value: IIN is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: IIN is poor value based on its PE Ratio (151.3x) compared to the US Medical Equipment industry average (44.6x).

PE vs Market: IIN is poor value based on its PE Ratio (151.3x) compared to the US market (16.8x).


Price to Earnings Growth Ratio

PEG Ratio: IIN is poor value based on its PEG Ratio (1.3x)


Price to Book Ratio

PB vs Industry: IIN is good value based on its PB Ratio (1.6x) compared to the US Medical Equipment industry average (3.7x).


Future Growth

How is IntriCon forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

118.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IIN's forecast earnings growth (118.7% per year) is above the savings rate (2%).

Earnings vs Market: IIN's earnings (118.7% per year) are forecast to grow faster than the US market (13.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: IIN's revenue (13.1% per year) is forecast to grow faster than the US market (9.8% per year).

High Growth Revenue: IIN's revenue (13.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if IIN's Return on Equity is forecast to be high in 3 years time


Past Performance

How has IntriCon performed over the past 5 years?

-11.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IIN has a large one-off loss of $3.1M impacting its September 30 2021 financial results.

Growing Profit Margin: IIN became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: IIN has become profitable over the past 5 years, growing earnings by -11.7% per year.

Accelerating Growth: IIN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: IIN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (51.2%).


Return on Equity

High ROE: IIN's Return on Equity (1.1%) is considered low.


Financial Health

How is IntriCon's financial position?


Financial Position Analysis

Short Term Liabilities: IIN's short term assets ($79.3M) exceed its short term liabilities ($21.5M).

Long Term Liabilities: IIN's short term assets ($79.3M) exceed its long term liabilities ($9.0M).


Debt to Equity History and Analysis

Debt Level: IIN is debt free.

Reducing Debt: IIN has no debt compared to 5 years ago when its debt to equity ratio was 44.2%.

Debt Coverage: IIN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: IIN has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is IntriCon current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IIN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IIN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IIN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IIN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IIN's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

J. Longval (44 yo)

1.17yrs

Tenure

US$650,071

Compensation

Mr. J. Scott Longval has been Chief Executive Officer, President and Director of IntriCon Corporation since October 1, 2020. He served as an Executive Vice President at IntriCon Corporation until September...


CEO Compensation Analysis

Compensation vs Market: J.'s total compensation ($USD650.07K) is about average for companies of similar size in the US market ($USD567.11K).

Compensation vs Earnings: J.'s compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: IIN's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

Experienced Board: IIN's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.


Top Shareholders

Company Information

IntriCon Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: IntriCon Corporation
  • Ticker: IIN
  • Exchange: NasdaqGM
  • Founded: 1930
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$145.833m
  • Shares outstanding: 9.14m
  • Website: https://www.intricon.com

Number of Employees


Location

  • IntriCon Corporation
  • 1260 Red Fox Road
  • Arden Hills
  • Minnesota
  • 55112
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/07 00:19
End of Day Share Price2021/12/06 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.